Soleno Therapeutics Inc (SLNO) — Free Cash Flow Generation Index
Soleno Therapeutics Inc (SLNO) has a Free Cash Flow Generation Index of 1.00x as of March 2026. Free cash flow of $25.94 Million represents 1% of operating cash flow ($25.98 Million). Read Soleno Therapeutics Inc debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Soleno Therapeutics Inc Free Cash Flow Generation Index (2025–2025)
Historical FCF Generation Index trend for Soleno Therapeutics Inc across 1 annual periods. Explore capital reinvestment ratio of Soleno Therapeutics Inc to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Soleno Therapeutics Inc (2025–2025)
Year-by-year Free Cash Flow Generation Index for Soleno Therapeutics Inc. For the full company profile including market capitalisation, see market value of Soleno Therapeutics Inc.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | $46.73 Million | $46.80 Million | $73.00K | — |